1. Thailand Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
Bumrungrad Hospital Public Co., Ltd.

Bumrungrad Hospital Public Co., Ltd.

198.50
THB
+2.00
(+1.02%)
8.82EPS
19.67P/E
149.45BMarket Cap
Nov 05Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
19.69
21.45
24.24
24.59
24.82
25.15
25.35
15.82
15.68
26.07
31.92
32.35
31.72
32.1
Basic EPS, GAAP
3.46
3.75
4.72
4.98
5.41
5.7
5.14
1.54
1.53
6.21
8.81
9.78
9.45
9.56
Free Cash Flow per Basic Share
1.43
3.61
3.36
3.73
4.91
5.27
4.13
1.62
3.26
6.28
6.82
9.25
7.74
5.4
Dividend per Share
1.9
1.9
2.15
2.4
2.55
2.8
2.95
3.25
3.2
3.2
3.7
5.16
5
11
Book Value per Share
13.17
14.94
17.48
19.86
22.51
25.32
27.4
23.32
21.75
24.79
29.94
34.58
38.82
34.44
Tangible Book Value per Share
12.91
14.58
17.08
19.26
21.67
24.14
26.25
22.34
20.76
23.9
29.1
33.76
37.92
33.42
Basic Weighted Avg Shares
729
729
729
729
729
729
729
782
795
795
795
795
795
795
Sales/Revenue/Turnover
14,346
15,630
17,660
17,915
18,087
18,326
18,474
12,362
12,460
20,721
25,376
25,718
25,215
25,525
Operating Margin (%)
21.47
21.91
24.01
24.87
26.73
27.73
24.48
11.07
12.66
29.01
33.39
35.73
36.07
36.08
Depreciation Expense
882
1,045
1,045
1,139
1,206
1,180
1,223
1,220
1,180
1,117
1,097
1,077
1,068
1,126
Net Income, GAAP
2,521
2,730
3,436
3,626
3,944
4,152
3,748
1,204
1,216
4,938
7,006
7,775
7,512
7,599
Effective Tax Rate (%)
19.88
20.04
19.37
17.68
17.58
17.48
17.06
10.92
14.83
17.73
18.32
17
18.68
18.73
Profit Margin (%)
17.57
17.47
19.46
20.24
21.81
22.66
20.29
9.74
9.76
23.83
27.61
30.23
29.79
29.77
Working Capital
5,389
6,177
6,032
6,445
6,903
9,217
9,097
6,383
5,778
8,004
11,501
12,818
14,696
10,036
LT Debt
5,142
5,152
3,664
3,689
2,508
2,512
2,513
74
54
40
74
102
84
78
Total Equity
9,597
11,260
13,100
14,788
16,705
18,744
20,265
18,837
17,618
20,005
24,098
27,801
31,171
27,713
Return on Invested Capital (%)
17.18
17.31
19.43
19.76
20.34
19.9
16.79
5.54
6.66
25.95
30.71
28.69
24.56
25.72
Return on Capital (%)
18.71
18.45
20.73
20.83
20.94
20.49
17.38
5.88
6.61
25.95
31.45
29.64
25.21
26.55
Return on Common Equity (%)
27.85
26.67
29.1
26.66
25.55
23.82
19.51
6.25
6.79
26.7
32.21
30.32
25.75
27.13

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
23
22
22
LT Borrowings
23
24
24
LT Finance Leases
61
58
54
Preferred Equity and Hybrid Capital
1
1
1
Shares Outstanding
795
795
795
Market Capitalization
125,207
129,580
149,454

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
18,781
20,110
14,281
Cash, Cash Equivalents & STI
13,948
14,340
7,565
Accounts Receivable, Net
4,269
5,219
6,139
Inventories
371
322
317
Total Current Liabilities
4,085
4,485
4,245
Payables & Accruals
3,841
4,207
3,945
ST Debt
23
22
22
Deferred Revenue
- -
- -
- -

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.41%
11.01%
12.12%
Free Cash Flow
19.55%
44.99%
-16.25%
Net Income, GAAP
29.86%
71.33%
-3.38%
Sales/Revenue/Turnover
6.04%
17.79%
-1.95%
Total Cash Common Dividend
10.33%
10.4%
-3.08%

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6,537
6,303
6,405
6,473
25,718
2025
6,141
6,024
6,513
6,537
25,215
2026
6,224
6,251
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.5
2.43
2.46
2.39
9.78
2025
2.18
2.34
2.56
2.37
9.45
2026
2.25
2.38
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
3.15
2.01
- -
5.16
2025
- -
3
2
- -
5
2026
- -
9
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Artirat Charukitpipat
Full Time Employees
27,987
Sector
Health services
Industry
Hospital/Nursing management
Address
33 Sukhumvit Soi 3 (Nana Nua) Bangkok BM Thailand 10110
IPO Date
Dec 15, 1989
Website
bumrungrad.com
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
HCA Healthcare, Inc. (NYSE:HCA)
Business
Bumrungrad Hospital Public Company Limited (BH.BK) owns and operates Bumrungrad International Hospital, Southeast Asia's largest private hospital, and multiple affiliated healthcare entities providing comprehensive medical, surgical, diagnostic, wellness, and specialized services to over 1.1 million patients annually from more than 190 countries. Core offerings encompass inpatient and outpatient care across 47 specialty centers and clinics including cardiology, cardiothoracic surgery, neurology, neurosurgery, orthopedics, joint replacement, oncology, gastroenterology, endocrinology, pediatrics, dermatology, aesthetics, obstetrics, gynecology, urology, nephrology, emergency medicine, rehabilitation, psychiatry, spine care, breast health, ophthalmology, and fertility services; advanced diagnostics such as MRI, CT, PET scans; modern operating theaters for robotic-assisted surgeries including da Vinci Xi system; intensive care units; dialysis; dental care; and wellness programs via VitalLife Scientific Wellness Center and VitalLife Skin Clinic. The company also provides international patient services with multilingual support, concierge coordination, electronic medical records, and packages for check-ups, therapeutics, and rehabilitation. Founded in 1980 and headquartered in Bangkok, Thailand, the company operates primarily from its flagship 580-bed facility in Bangkok, which generates over 97% of revenues, alongside Bumrungrad International Clinic, Bumrungrad International Dialysis Clinic, Esperance Cancer Clinic, and VitalLife entities in Bangkok; Bumrungrad Clinic Yangon in Myanmar; and Ulaanbaatar Songdo Hospital in Mongolia. It serves a diverse patient base with 65% of revenues from international markets, led by Qatar, Myanmar, the United States, Middle East countries including Saudi Arabia and UAE, CLMV region, China, and Bangladesh, alongside domestic Thai patients. In recent developments, the company reported record Q2 2025 core operating EBITDA margin of 41.6% amid strong Middle East recovery with revenues up 23% quarter-on-quarter, including 54% growth from Saudi Arabia; advanced construction of the Bumrungrad Comprehensive Cancer Center and Bumrungrad International Hospital Phuket, both slated for 2027 opening to expand oncology, complex care, and wellness tourism capacities; expanded robotic surgery with 24 da Vinci procedures in mid-2025 and trained 23 surgeons; deepened strategic partnerships across insurance, banking, real estate, and wellness via VitalLife integration for preventive medicine; and achieved global rankings including 100th in Newsweek's World's Best Hospitals 2025.